Evidence map›Paper›PMID 40267255›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2025

[Association of T CD3+/T CD8+ lymphocytes in lymphatic and perineural infiltration in colorectal cancer].

Edgar Joaquín Cortés-Torres, María Del Refugio Flores-Betancourt, Alejandro González-Ojeda, Clotilde Fuentes-Orozco, Gabino Cervantes-Guevara, Enrique Cervantes-Pérez, Alejandro Ramírez-Velázquez, Ana Karen Hernández-Guzmán

Abstract readEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Edgar Joaquín Cortés-TorresInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio García Téllez", Servicio de Cirugía Oncológica. Guadalajara, Jalisco, México.ORCID 0000-0002-0430-2888
María Del Refugio Flores-BetancourtInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio García Téllez", Servicio de Cirugía Oncológica. Guadalajara, Jalisco, México.ORCID 0009-0008-5859-5752
Alejandro González-OjedaInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio García Téllez", Unidad de Investigación Biomédica 02. Guadalajara, Jalisco, México.ORCID 0000-0003-2935-8703
Clotilde Fuentes-OrozcoInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio García Téllez", Unidad de Investigación Biomédica 02. Guadalajara, Jalisco, México.ORCID 0000-0001-6230-8359
Gabino Cervantes-GuevaraInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio García Téllez", Unidad de Investigación Biomédica 02. Guadalajara, Jalisco, México.ORCID 0000-0001-6249-4737
Enrique Cervantes-PérezHospital Civil de Guadalajara Fray Antonio Alcalde, Departamento de Medicina Interna. Guadalajara, Jalisco, México.ORCID 0000-0002-6333-9082
Alejandro Ramírez-VelázquezInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio García Téllez", Unidad de Investigación Biomédica 02. Guadalajara, Jalisco, México.ORCID 0009-0008-6323-2999
Ana Karen Hernández-GuzmánInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio García Téllez", Departamento de Cirugía General. Guadalajara, Jalisco, México.ORCID 0000-0002-5007-5778

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colorectal cancer (CRC) is one of the most common and lethal neoplasia in the world. Key prognostic factors include lymphovascular and perineural infiltration, which negatively affect the disease by increasing the risk of metastasis. Studies indicate that low levels of CD8+ and CD3+ T cells may be associated with early metastasis. Objective: To evaluate the sensitivity and specificity of preoperative serum cytotoxic T lymphocytes (CD8+ and CD3+) with lymphatic and perineural infiltration in colorectal cancer. Material and methods: Prospective, cross-sectional, analytical study on cytotoxic T lymphocytes (CD8+ and CD3+). Descriptive statistics, measures of central tendency and dispersion for quantitative variables, frequency and percentage for qualitative variables were used. The samples obtained were associated with the presence of lymphovascular or perineural infiltration. Results: 37 patients were included, with a mean age of 58 ± 10.9 years; 24 (64.8%) were female. 16 (43.2%) were diagnosed with malignant colon neoplasms, and 21 (56.7%) with malignant rectal tumors. Lymphovascular infiltration was found in 13 (35.1%) and 18 (48.6%) perineural infiltrates. CD8+ T lymphocyte levels were 219 cells/AL ± 140.5 cells/AL, and 16 (43.2%) had low levels. CD3+ T lymphocytes averaged with 943 cells/uL ± 640.4 cells/AL, and 16 (43.2%) had low levels. Conclusions: Histopathologically we found an association between the serum level of CD3+ and CD8+ T cells and lymphovascular and perineural infiltration. Additional research has to be done to strengthen the results obtained.

Indexed as

CD3 ComplexCD8-Positive T-LymphocytesColorectal NeoplasmsLymphocytes, Tumor-InfiltratingAdultAgedCross-Sectional StudiesFemaleHumansLymphatic MetastasisMaleMiddle AgedPeripheral NervesProspective StudiesSensitivity and SpecificityCD3 ComplexColorectal NeoplasmsLymphocytesNeoplasm MetastasisPrognosisSerum

Identifiers

PMID40267255
PMCPMC12068896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.